Device Trial Radar · NCT06668909
Patient Reported Outcomes With WaveLight LASIK
Last checked: Nov 19, 2026Latest source record: Mar 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Nov 1, 2024
Primary completion
Feb 14, 2025
Study completion Feb 14, 2025
Sponsor
- Lead sponsor
- OVO LASIK + LensAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Sengi
- First posted
- Nov 1, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 35 years
Summary
As written by the sponsor on the registry.
This study is a multi-site, single-arm, ambispective, observational study of subject satisfaction, after successful bilateral LASIK surgery. Subjects will be assessed 12+ months post-operatively. Clinical evaluations will include administration of the OSDI, modified PROWL, and dry eye questionnaires.
Conditions
- Myopia
Interventions
WaveLight® EX500Device
Phorcidies Planned Contoura LASIK
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient SatisfactionTime frame: 12 months postoperatively
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
NVISION Eye Centers
San Diego, California
Boston Vision
Brookline, Massachusetts
Ovo Lasik + Lens
Saint Louis Park, Minnesota
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.